Category:
Other Preparations
CAS NO:
204656-20-2
Standard:
USP,
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that plays a role in glucose regulation and appetite control. It is used for the management of type 2 diabetes mellitus and for weight management in certain populations.
Liraglutide Injection is a pharmaceutical formulation of glucagon-like peptide-1 receptor agonist. It utilizes recombinant DNA technology for synthesis, featuring a fatty acid side chain to extend serum half-life via albumin binding.